{"id":"https://openalex.org/G5962338457","display_name":"TRAFFICKING AND FUNCTION OF MU-OPIOD RECEPTOR GENETIC VARIANTS","description":"PUBLIC HEALTH RELEVANCE: The use of opioid analgesics to treat pain is highly hampered by variability in patient responses, adverse reactions, and addiction. It is established that genetic factors contribute to this variability, but how they do so is unknown. Understanding how prevalent variations in the mu opioid receptor (MOR), the main target of opioid analgesics, change opioid physiology will broadly improve our understanding of the cellular processes underlying the development of tolerance and dependence to many drugs that are currently abused, and provide a platform for designing better and personalized therapeutic strategies towards combating neuropsychiatric disorders and drug abuse.            ","funder_award_id":"R21DA036086","funder":{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","doi":"https://doi.org/10.13039/100000026"},"funded_outputs":["https://openalex.org/W28264976","https://openalex.org/W869438964","https://openalex.org/W2013526312","https://openalex.org/W2014937827","https://openalex.org/W2078201172","https://openalex.org/W2086185520","https://openalex.org/W2087884923","https://openalex.org/W2149420045","https://openalex.org/W2199154665","https://openalex.org/W2357419851","https://openalex.org/W2395850231","https://openalex.org/W2585718662","https://openalex.org/W2593532843","https://openalex.org/W2618737030","https://openalex.org/W2907181335"],"funded_outputs_count":15,"parent_awards":[],"sub_awards":[],"sub_awards_count":0,"amount":null,"currency":"USD","amount_usd":null,"amount_usd_basis":null,"recipients":[],"recipient_countries":[],"recipient_regions":[],"research_scope":{"is_research":true,"basis":"funder_default","tier":1},"funding_type":"research","funder_scheme":"R21","start_date":"2013-09-15","end_date":"2015-08-31","start_year":2013,"end_year":2015,"landing_page_url":"https://reporter.nih.gov/project-details/8734364","doi":null,"provenance":"nih_exporter","lead_investigator":{"given_name":"MANOJKUMAR A","family_name":"PUTHENVEEDU","orcid":null,"role_start":null,"affiliation":{"name":"CARNEGIE-MELLON UNIVERSITY","country":"UNITED STATES","ids":null},"author":{"id":"https://openalex.org/A5007160724","display_name":"Manojkumar A. Puthenveedu","orcid":"https://orcid.org/0000-0002-3177-4231"},"institutions":[{"id":"https://openalex.org/I74973139","display_name":"Carnegie Mellon University","ror":"https://ror.org/05x2bcf33","country_code":"US","type":"education","lineage":["https://openalex.org/I74973139"]}]},"co_lead_investigator":null,"investigators":null,"works_api_url":"https://api.openalex.org/works?filter=awards.id:G5962338457","primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.4229,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.4229,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.1533,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.1417,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mu-opioid-receptor","display_name":"mu-opioid receptor","score":0.876},{"id":"https://openalex.org/keywords/genetic-variants","display_name":"genetic variants","score":0.953},{"id":"https://openalex.org/keywords/opioid-analgesics","display_name":"opioid analgesics","score":0.913},{"id":"https://openalex.org/keywords/opioid-tolerance","display_name":"opioid tolerance","score":0.59},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.809},{"id":"https://openalex.org/keywords/drug-abuse","display_name":"drug abuse","score":0.66},{"id":"https://openalex.org/keywords/personalized-medicine","display_name":"personalized medicine","score":0.593},{"id":"https://openalex.org/keywords/pain-management","display_name":"pain management","score":0.523},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.61},{"id":"https://openalex.org/keywords/drug-trafficking","display_name":"drug trafficking","score":0.559}],"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391}],"institution_awarded":[{"id":"https://openalex.org/I74973139","display_name":"Carnegie Mellon University","ror":"https://ror.org/05x2bcf33","country_code":"US","type":"education","lineage":["https://openalex.org/I74973139"]}],"updated_date":"2026-11-13T03:01:57.000Z","created_date":"2026-10-09T19:56:01.000Z"}
